Literature DB >> 19407992

Cannabinoid-induced conditioned place preference in the spontaneously hypertensive rat-an animal model of attention deficit hyperactivity disorder.

Pablo Pandolfo1, Leandro F Vendruscolo, Regina Sordi, Reinaldo N Takahashi.   

Abstract

RATIONALE: Cannabis preparations are the most widely consumed illicit drugs, and their use typically begins in adolescence. The prevalence of cannabis abuse is higher in patients with attention deficit/hyperactivity disorder (ADHD) than in the general population, yet, knowledge about the motivational properties of cannabinoids in animal models of ADHD are lacking.
OBJECTIVE: To compare the motivational effects of the synthetic cannabinoid agonist WIN55,212-2 (WIN) in adolescent and adult spontaneously hypertensive rats (SHR), a validated animal model of ADHD, and Wistar rats, representing a "normal" genetically heterogeneous population. We also asked whether the effects of WIN depended (1) on the activation of the cerebral subtype of cannabinoid receptors, namely, the CB(1) cannabinoid receptor and (2) on putative changes by WIN in blood pressure.
METHODS: WIN was tested under an unbiased conditioned place preference (CPP) paradigm. Blood pressure after WIN administration was also monitored in additional groups of rats.
RESULTS: In the Wistar rats, WIN produced place aversion only in the adult but not adolescent rats. In contrast, WIN produced CPP in both adolescent and adult SHR rats. The behavioral effects of WIN were CB(1)-mediated and not related to blood pressure.
CONCLUSION: The contrasting effects of WIN in Wistar and SHR, and the higher resistance of adolescent rats to the aversive and rewarding effects of WIN in these two strains suggests that both adolescence and the ADHD-like profile exhibited by the SHR strain constitute factors that influence the motivational properties of cannabinoids.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19407992     DOI: 10.1007/s00213-009-1542-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  61 in total

1.  Development of a strain of spontaneously hypertensive rats.

Authors:  K OKAMOTO; K AOKI
Journal:  Jpn Circ J       Date:  1963-03

Review 2.  Involvement of the endocannabinoid system in drug addiction.

Authors:  Rafael Maldonado; Olga Valverde; Fernando Berrendero
Journal:  Trends Neurosci       Date:  2006-02-17       Impact factor: 13.837

3.  Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.

Authors:  K D Lake; D R Compton; K Varga; B R Martin; G Kunos
Journal:  J Pharmacol Exp Ther       Date:  1997-06       Impact factor: 4.030

4.  Intravenous self-administration of drugs in rats.

Authors:  J M van Ree; J L Slangen; D de Wied
Journal:  J Pharmacol Exp Ther       Date:  1978-03       Impact factor: 4.030

5.  Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder.

Authors:  Patrick N Augustyniak; Said Kourrich; Shohreh M Rezazadeh; Jane Stewart; Andreas Arvanitogiannis
Journal:  Behav Brain Res       Date:  2005-10-24       Impact factor: 3.332

6.  A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice.

Authors:  E Valjent; R Maldonado
Journal:  Psychopharmacology (Berl)       Date:  2000-01       Impact factor: 4.530

Review 7.  Animal models of attention-deficit hyperactivity disorder.

Authors:  Eugen Davids; Kehong Zhang; Frank I Tarazi; Ross J Baldessarini
Journal:  Brain Res Brain Res Rev       Date:  2003-04

8.  Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.

Authors:  V Russell; A de Villiers; T Sagvolden; M Lamm; J Taljaard
Journal:  Brain Res       Date:  1995-04-10       Impact factor: 3.252

9.  Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats.

Authors:  A J Wheal; T Bennett; M D Randall; S M Gardiner
Journal:  Br J Pharmacol       Date:  2007-08-13       Impact factor: 8.739

10.  Lack of evidence for appetitive effects of Delta 9-tetrahydrocannabinol in the intracranial self-stimulation and conditioned place preference procedures in rodents.

Authors:  Styliani Vlachou; George G Nomikos; David N Stephens; George Panagis
Journal:  Behav Pharmacol       Date:  2007-07       Impact factor: 2.293

View more
  16 in total

Review 1.  Emergence of sex differences in the development of substance use and abuse during adolescence.

Authors:  Cynthia Kuhn
Journal:  Pharmacol Ther       Date:  2015-06-03       Impact factor: 12.310

2.  Necessity for research directed at stimulant type and treatment-onset age to access the impact of medication on drug abuse vulnerability in teenagers with ADHD.

Authors:  Kathleen M Kantak; Linda P Dwoskin
Journal:  Pharmacol Biochem Behav       Date:  2016-03-22       Impact factor: 3.533

3.  Δ(9)-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids in mice and rats.

Authors:  Michael B Gatch; Michael J Forster
Journal:  Psychopharmacology (Berl)       Date:  2016-02-15       Impact factor: 4.530

4.  Methylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function.

Authors:  Roxann C Harvey; Sucharita Sen; Agripina Deaciuc; Linda P Dwoskin; Kathleen M Kantak
Journal:  Neuropsychopharmacology       Date:  2010-12-08       Impact factor: 7.853

5.  Direct intra-accumbal infusion of a beta-adrenergic receptor antagonist abolishes WIN 55,212-2-induced aversion.

Authors:  Ana Franky Carvalho; Elisabeth J Van Bockstaele
Journal:  Neurosci Lett       Date:  2011-06-15       Impact factor: 3.046

6.  Contribution of limbic norepinephrine to cannabinoid-induced aversion.

Authors:  Ana Franky Carvalho; Arith-Ruth S Reyes; Robert C Sterling; Ellen Unterwald; Elisabeth J Van Bockstaele
Journal:  Psychopharmacology (Berl)       Date:  2010-07-03       Impact factor: 4.530

7.  Cannabinoid conditioned reward and aversion: behavioral and neural processes.

Authors:  Jennifer E Murray; Rick A Bevins
Journal:  ACS Chem Neurosci       Date:  2010-03-10       Impact factor: 4.418

Review 8.  The emergence of gonadal hormone influences on dopaminergic function during puberty.

Authors:  Cynthia Kuhn; Misha Johnson; Alex Thomae; Brooke Luo; Sidney A Simon; Guiying Zhou; Q David Walker
Journal:  Horm Behav       Date:  2009-11-10       Impact factor: 3.587

9.  Long-term cognitive impairments induced by chronic cannabinoid exposure during adolescence in rats: a strain comparison.

Authors:  Justine Renard; Marie-Odile Krebs; Thérèse M Jay; Gwenaëlle Le Pen
Journal:  Psychopharmacology (Berl)       Date:  2012-09-16       Impact factor: 4.530

Review 10.  Endocannabinoid signaling in the etiology and treatment of major depressive illness.

Authors:  Cecilia J Hillard; Qing-song Liu
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.